Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KD.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XCSNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.7.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.15.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.40NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CR.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
KB.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CJ.1.3.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XANNWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BN.1.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DV.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.53NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.4.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EU.1.1.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CM.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.43NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
HU.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
JB.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.277NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-211.894South Korea
AY.28 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.272NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.371NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.353NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.407NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AA.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.182NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.218NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBB.1.12.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.11NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.22 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.128NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.36.33NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.405NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.296NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.412NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AC.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.27NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.421NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.364NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.82NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.61NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.47NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.38NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.251NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used